FIBRINOLYTIC AND PROTEOLYTIC ACTIVITY OF BLOOD PLASMA IN PEPTIC ULCER OF THE STOMACH, TAKING INTO ACCOUNT THE PATHOGENIC STRAINS OF HELICOBACTER PYLORI
PDF (Українська)

Keywords

peptic gastric ulcer, Helicobacter pylori strains, fibrinolytic and proteolytic activity

How to Cite

L. M. Honcharuk, O. I. Fediv, V. T. Kulachek, & Y. M. Teleki. (2020). FIBRINOLYTIC AND PROTEOLYTIC ACTIVITY OF BLOOD PLASMA IN PEPTIC ULCER OF THE STOMACH, TAKING INTO ACCOUNT THE PATHOGENIC STRAINS OF HELICOBACTER PYLORI. Eastern Ukrainian Medical Journal, 8(1), 1-7. https://doi.org/10.21272/eumj.2020;8(1):1-7

Abstract

The purpose of the study is to investigate changes in fibrinolytic and proteolytic activity of blood plasma in patients with peptic ulcer (PU) taking into account pathogenic Helicobacter pylori (Hp) strains.

Materials and methods. 93 patients with PU were examined, of which 30 patients with PU and concomitant Hp cag cag A+/vac A+ (group I), 31 patients with PU and concomitant Hp cag A-/vac A- (group II), 32 patients with PU without concomitant HP infection (group III). The control group consisted of 30 healthy individuals. Fibrinolytic activity of blood plasma was investigated with the help of lysis of azofibrin (fibrin associated with the azo dye orange), which in the alkaline medium turns a bright red color. The level of total (ТFA), enzymatic (FFA) and non-enzymatic fibrinolytic activity (NFA) was evaluated. Proteolytic activity of blood plasma was determined by the lysis of azoalbumin, azocasein and azokol.

Research results. The study of fibrinolytic activity of blood plasma showed that the total fibrinolytic activity of blood plasma (TFA) in all groups was significantly higher compared to the control indicators: in patients of group I by 61.5 %, in patients by 40.9 %, in patients of group III by 30.3 %, with a significant intergroup difference between the groups. The growth of TFA was mainly due to FFA. In patients of group I, FFA increased by 2.06 times (p < 0.05), and in patients of group II – by 1.79 times (p < 0.05), in patients of group IIІ – by 1.52 times (p < 0.05) compared with the control. In patients with group I, FFA increased by 12.5 % ​​(p < 0.05) compared with group II. In all patients examined, there was an increase in the proteolytic activity of blood plasma, in particular in group I, the lysis of azoalbumin, azocasein and azocolol increased significantly 2.94 times, 2.83 times and 1.90 times, respectively, and in the patients of group II the investigated indicators increased accordingly 1.87-fold (p < 0.05), 1.96-fold (p < 0.05) and 1.40-fold (p < 0.05), in patients of group III, respectively 1.55 times (p < 0.05), 1.59 times (p < 0.05) and 1.18 times, compared to these values ​​in almost healthy subjects. Significantly more significant changes in proteolysis were detected in the presence of pathogenic Hp strains.

Conclusion. Increased proteolytic and fibrinolytic activity of blood plasma is observed in patients with PU. The presence of concomitant Hp in PU leads to more pronounced changes in proteolysis and fibrinolysis. Pathogenic strains of Hp cag cag A+/vac A+ cause significantly more abnormalities in hemostasis.

https://doi.org/10.21272/eumj.2020;8(1):1-7
PDF (Українська)

References

1. Mykhalskyi AV, Mykhalska YuA. [Features of physical therapy of gastric ulcer and duodenum at different stages of rehabilitation]. Visnyk Kamianets-Podilskoho natsionalnoho universytetu imeni Ivana Ohiienka. Fizychne vykhovannia, sport i zdorovia liudyny. 2018;(11):246-253. Режим доступу: http://nbuv.gov.ua/UJRN/
2. Dudnykova EV, Hylys EV, Zazian VH, Zazian AV, Chernova MS. [Influence of Helicobacter Pylori Dupa pathogenicity factors on the character of morphological pattern of gastric mucosa in diseases of the upper gastrointestinal tract in children]. Kubanskyi nauchnуi medytsynskyi vestnyk. 2016;(3):59-62. https://doi.org/10.25207/1608-6228-2016-3-59-62
3. Pozdeev OK, Pozdeeva AO, Valeeva YuV, Huliaev PE. [Mechanisms of interaction of Helicobacter pylori with gastric mucosa epithelium. and pathogenicity factors contributing to successful colonization]. Infektsyia i immunitet. 2018;8(3):273-283. https://doi.org/10.15789/2220-7619-2018-3-273-283
4. Fadieienko HD, Kolesnikova OV. [Helicobacter pylori eradication: how to improve the effectiveness of therapy?]. Suchasna hastroenterolohiia. 2015;2(82):66-72. Режим доступу: http://nbuv.gov.ua/UJRN/SGastro_2015_2_11.
5. Bastos J, Peleteiro B, Pinto H, Marinho A, Guimarães JT, Ramos E, et al. Prevalence, incidence and risk factors for Helicobacter pylori infection in a cohort of Portuguese adolescents (EpiTeen). Dig Liver Dis. 2013;45(4):290-5. doi: 10.1016/j.dld.2012.11.009.
6. Kanovska LV, Kaushanska OV, Bedyk NM, Novytska IO. [Helicobacter pylori as an urgent problem of modern gastroenterology (literature review)]. Molodyi vchenyi. 2016;(2):156-160. Режим доступу: http://nbuv.gov.ua/UJRN/molv_2016_2_40
7. Baudron CR, Franceschi F, Salles N, Gasbarrini A. Extragastric diseases and Helicobacter pylori. Helicobacter. 2013;(18 Suppl 1):44-51. doi: 10.1111/hel.12077.
8. Bridge DR, Merrell DS. Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease. Gut Microbes. 2013;4(2):101-17. doi: 10.4161/gmic.23797.
9. Kim A, Servetas SL, Kang J, Kim J, Jang S, Cha HJ, et al. Helicobacter pylori bab Paralog Distribution and Association with cagA, vacA, and homA/B Genotypes in American and South Korean Clinical Isolates. PLoS One. 2015;10(8):0137078. doi: 10.1371/journal.pone.0137078.
10. Ysaeva HSh, Valyeva RY. [Biological properties and virulence of Helicobacter pylori]. Klynycheskaia mykrobyolohyia y antymykrobnaia khymyoterapyia. 2018;(1):14-22.
11. Venerucci F. Histopathology kits: methods and applicationsю Bologna, Milan: Bio-Optica, 2001.95 p.
12. Kravchenko NA, Yarmysh NV. [Biochemical and molecular genetic mechanisms of regulation of nitric oxide synthesis by endothelial NO synthase in normal and cardiovascular pathology]. Ukrainskyi terapevtychnyi zhurnal. 2007;(1):82-89.
13. Veremeenko KN, Holoborodko OP, Kyzym AY. Proteolyz v norme y pry patolohy [Proteolysis is normal and pathologists]. K: Zdorovia, 1988.198p.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.